News Daily News Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years L.A. McKeown September 17, 2020
News Daily News DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms Caitlin E. Cox July 11, 2019
News Conference News SCAI 2019 Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics Yael L. Maxwell May 21, 2019
News Conference News CRT 2019 Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy L.A. McKeown March 06, 2019
News Daily News No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds L.A. McKeown March 01, 2019
News Conference News ISET 2019 Eluvia Sustains Lead Over Zilver PTX in Patients With Diabetes: IMPERIAL Subanalysis Caitlin E. Cox January 30, 2019
News Daily News IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease L.A. McKeown January 25, 2019
News Conference News TCT 2018 IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease Todd Neale September 22, 2018
News Conference News VIVA 2017 DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease L.A. McKeown September 13, 2017
News Conference News ISET 2016 Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired Michael O'Riordan February 10, 2016
News Daily News Zilver Stent Seen as Welcome Addition to PAD Armamentarium L.A. McKeown November 25, 2012
News Daily News Drug-Eluting Balloon Continues Strong Showing in SFA Lesions Jason Kahn March 22, 2012
News Daily News Drug-Eluting Balloon Continues to Show Positive Results in SFA, Popliteal Disease Jason Kahn September 15, 2011